M&G PLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 665,988 shares of the healthcare conglomerate's stock after selling 79,299 shares during the period. UnitedHealth Group comprises about 1.2% of M&G PLC's holdings, making the stock its 21st largest position. M&G PLC owned 0.07% of UnitedHealth Group worth $244,418,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. City State Bank increased its position in UnitedHealth Group by 5.6% during the third quarter. City State Bank now owns 471 shares of the healthcare conglomerate's stock worth $173,000 after buying an additional 25 shares during the period. Murphy Pohlad Asset Management LLC increased its stake in UnitedHealth Group by 0.5% in the 3rd quarter. Murphy Pohlad Asset Management LLC now owns 5,305 shares of the healthcare conglomerate's stock valued at $1,947,000 after purchasing an additional 25 shares in the last quarter. LFG Wealth Partners LLC raised its holdings in UnitedHealth Group by 3.3% during the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate's stock worth $355,000 after purchasing an additional 27 shares during the last quarter. Synergy Financial Group LTD raised its holdings in UnitedHealth Group by 3.1% during the second quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate's stock worth $369,000 after purchasing an additional 27 shares during the last quarter. Finally, Ares Financial Consulting LLC boosted its position in UnitedHealth Group by 7.2% during the second quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate's stock worth $174,000 after purchasing an additional 28 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Trading Up 0.7%
UnitedHealth Group stock opened at $396.97 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The firm's 50-day moving average is $390.68 and its 200-day moving average is $364.28. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a market cap of $355.70 billion, a P/E ratio of 22.67, a PEG ratio of 1.48 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to analysts' expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. UnitedHealth Group's quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group's dividend payout ratio (DPR) is currently 53.00%.
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.19% of the company's stock.
Analysts Set New Price Targets
Several research analysts have recently issued reports on the company. BMO Capital Markets set a $512.00 price target on UnitedHealth Group in a research note on Tuesday, July 21st. Bank of America restated a "buy" rating and set a $450.00 target price on shares of UnitedHealth Group in a report on Monday, July 20th. Barclays reduced their price target on shares of UnitedHealth Group from $441.00 to $440.00 and set an "overweight" rating on the stock in a report on Wednesday, October 14th. Sanford C. Bernstein lowered their price target on shares of UnitedHealth Group from $512.00 to $500.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 14th. Finally, Truist Financial lifted their price objective on UnitedHealth Group from $440.00 to $480.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $463.93.
Get Our Latest Analysis on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.
Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.